Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Compressus

Explore full profile

Medical software company providing interoperability solutions

Washington DC, United StatesFounded 2000Biotech & Life Sciences
Valuation $25–50M Last recorded · 2009
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Compressus and the history behind them.

About Compressus

Founded in 2000 by John M. Falk, Compressus operates as a data integration and management platform for healthcare providers. The company's core intellectual property was initially designed for the U.S. Air Force to route time-sensitive medical images from military field operations. This foundation led to the development of its flagship product, MEDxConnect, a software solution that addresses medical imaging workflow and interoperability challenges across departments like Radiology, Cardiology, and Pathology. The company was acquired by Versata on December 24, 2015.

The business provides a software solution that connects disparate diagnostic acquisition devices, Picture Archiving and Communication Systems (PACS), Hospital Information Systems (HIS), and other departmental information systems. This allows healthcare organizations to create a unified and streamlined workflow. By acting as a central communications hub, MEDxConnect presents clinicians with relevant electronic patient information, clinical data, lab results, and medical images through a single, personalized virtual worklist. This approach is designed to improve productivity by 10% to 30%, with customers often achieving a return on investment in 6 to 15 months. The business model is based on selling this enterprise software solution, which can be deployed on-premise or in private and public clouds.

The MEDxConnect platform is built to be highly configurable, featuring a rules engine that automates workflows, such as auto-routing studies for subspecialty readings. Its core component, the Medical Message Mediator (M3), uses standards like HL7 and DICOM to control the flow of information between otherwise incompatible systems. This integration eliminates manual data re-entry and accelerates the healthcare delivery process. The platform includes several modules, such as an Order Mediator for facilities without a RIS/HIS, and a Document Mediator to digitize non-electronic documents. The system uses patented algorithms to balance work assignments across the enterprise by considering clinician availability and service level agreements, ultimately improving turnaround times and operational efficiency.

Source: Dealroom company data

At a glance

Founded
2000
Headquarters
Washington DC, United States
Sector
Biotech & Life Sciences

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • BNP Paribas
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Compressus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Compressus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.